Abstract #4303
Multimodal MRI of a novel transgenic model of Parkinsons Disease (MitoPark mice)
Linlin Cong 1 , Eric R. Muir 1 , Yusheng Qian 2 , Cang Chen 2 , Senlin Li 2 , and Timothy Q. Duong 1
1
Research Imaging Institute, University of
Texas Healthy Science Center at San Antonio, san
antonio, Texas, United States,
2
Departments
of Medicine and Pharmacology, University of Texas
Healthy Science Center at San Antonio, san antonio,
Texas, United States
Parkinsons disease (PD), the second most prevalent
neurodegenerative disorder, is characterized by a number
of motor symptoms. MitoPark transgenic mouse is a
relatively new model of PD that exhibits several
critical clinical features of PD, including progressive
neurodegeneration and death of dopamine neurons,
followed by motor dysfunction. This study investigated
CBF, ADC and T2* in the caudate putamen and substantia
nigra of MitoPark mice. MitoPark mice showed trends of
reduced ADC and CBF, and significantly reduced T2* value
compared to controls. These results were corroborated
with behavioral deficits in loco-motor activity and
histological loss of dopamine neurons.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
